These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| þ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| Delaware | 47-0702918 | |
| (State or other jurisdiction | (I.R.S. Employer | |
| of incorporation or organization) | Identification No.) | |
| 7405 Irvington Road, Omaha NE | 68122 | |
| (Address of principal executive offices) | (Zip code) |
| Large accelerated filer o | Accelerated filer o | Non-accelerated filer o | Smaller reporting company þ | |||
| (Do not check if a smaller reporting company) |
| PAGE | ||||||||
|
|
||||||||
|
|
||||||||
| 3 | ||||||||
|
|
||||||||
| 4 | ||||||||
|
|
||||||||
| 5 | ||||||||
|
|
||||||||
| 7 | ||||||||
|
|
||||||||
| 20 | ||||||||
|
|
||||||||
| 29 | ||||||||
|
|
||||||||
| 29 | ||||||||
|
|
||||||||
|
|
||||||||
| 30 | ||||||||
|
|
||||||||
| 30 | ||||||||
|
|
||||||||
| 31 | ||||||||
|
|
||||||||
| 31 | ||||||||
|
|
||||||||
| 31 | ||||||||
|
|
||||||||
| 31 | ||||||||
|
|
||||||||
| 31 | ||||||||
|
|
||||||||
| Exhibit 31.1 | ||||||||
| Exhibit 31.2 | ||||||||
| Exhibit 32.1 | ||||||||
| Exhibit 32.2 | ||||||||
2
| Item 1. |
Financial Statements
|
| December | September | |||||||
| 2009 | 2009 | |||||||
| (Unaudited) | ||||||||
|
ASSETS
|
||||||||
|
Current assets:
|
||||||||
|
Cash
|
$ | 517,964 | $ | 309,914 | ||||
|
Accounts receivable, less
allowance for doubtful accounts
of $0.9 million
at December 2009 and September 2009 |
23,681,183 | 28,393,198 | ||||||
|
Inventories, net
|
32,948,314 | 34,486,027 | ||||||
|
Deferred income taxes
|
1,703,413 | 1,701,568 | ||||||
|
Prepaid and other current assets
|
4,407,930 | 1,728,576 | ||||||
|
|
||||||||
|
Total current assets
|
63,258,804 | 66,619,283 | ||||||
|
|
||||||||
|
Property and equipment, net
|
11,642,259 | 11,256,627 | ||||||
|
Goodwill
|
6,149,168 | 5,848,808 | ||||||
|
Other intangible assets
|
4,959,519 | 3,373,269 | ||||||
|
Other assets
|
1,025,876 | 1,026,395 | ||||||
|
|
||||||||
|
|
$ | 87,035,626 | $ | 88,124,382 | ||||
|
|
||||||||
|
|
||||||||
|
LIABILITIES AND SHAREHOLDERS EQUITY
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable
|
$ | 13,914,745 | $ | 15,222,689 | ||||
|
Accrued expenses
|
5,895,614 | 6,768,924 | ||||||
|
Accrued wages, salaries and bonuses
|
2,003,255 | 3,257,832 | ||||||
|
Income taxes payable
|
904,099 | 3,984,258 | ||||||
|
Current maturities of credit facility
|
127,067 | 177,867 | ||||||
|
Current maturities of long-term debt
|
995,327 | 1,470,445 | ||||||
|
|
||||||||
|
Total current liabilities
|
23,840,107 | 30,882,015 | ||||||
|
|
||||||||
|
Credit facility, less current maturities
|
25,476,512 | 22,655,861 | ||||||
|
Deferred income taxes
|
1,268,662 | 1,256,713 | ||||||
|
Long-term debt, less current maturities
|
5,858,402 | 5,066,185 | ||||||
|
Other long-term liabilities
|
440,420 | | ||||||
|
|
||||||||
|
Series A cumulative, convertible preferred stock, $.01 par value
100,000 shares authorized and issued, liquidation preference
$25.00 per share
|
2,500,000 | 2,500,000 | ||||||
|
|
||||||||
|
Series B cumulative, convertible preferred stock, $.01 par value
80,000 shares authorized and issued, liquidation preference
$25.00 per share
|
2,000,000 | 2,000,000 | ||||||
|
|
||||||||
|
Shareholders equity:
|
||||||||
|
Preferred stock, $0.01 par, 1,000,000 shares authorized,
180,000 shares outstanding and issued in Series A and B
referred to above
|
| | ||||||
|
Common stock, $.01 par value, 3,000,000 shares authorized,
575,439 shares outstanding at December 2009 and 573,232
shares outstanding at September 2009
|
5,754 | 5,732 | ||||||
|
Additional paid-in capital
|
7,954,295 | 7,617,494 | ||||||
|
Retained earnings
|
17,691,474 | 16,140,382 | ||||||
|
|
||||||||
|
Total shareholders equity
|
25,651,523 | 23,763,608 | ||||||
|
|
||||||||
|
|
$ | 87,035,626 | $ | 88,124,382 | ||||
|
|
||||||||
3
| 2009 | 2008 | |||||||
|
|
||||||||
|
Sales (including excise taxes of $81.6 million
and $50.3 million, respectively
|
$ | 243,941,038 | $ | 217,377,363 | ||||
|
|
||||||||
|
Cost of sales
|
226,713,025 | 201,532,714 | ||||||
|
|
||||||||
|
Gross profit
|
17,228,013 | 15,844,649 | ||||||
|
|
||||||||
|
|
||||||||
|
Selling, general and administrative expenses
|
13,778,739 | 12,797,583 | ||||||
|
Depreciation and amortization
|
387,269 | 310,334 | ||||||
|
|
||||||||
|
|
14,166,008 | 13,107,917 | ||||||
|
|
||||||||
|
Operating income
|
3,062,005 | 2,736,732 | ||||||
|
|
||||||||
|
Other expense (income):
|
||||||||
|
Interest expense
|
405,245 | 489,199 | ||||||
|
Other (income), net
|
(13,380 | ) | (14,067 | ) | ||||
|
|
||||||||
|
|
391,865 | 475,132 | ||||||
|
|
||||||||
|
|
||||||||
|
Income from continuing operations
before income taxes
|
2,670,140 | 2,261,600 | ||||||
|
|
||||||||
|
Income tax expense
|
941,000 | 860,000 | ||||||
|
|
||||||||
|
Income from continuing operations
|
1,729,140 | 1,401,600 | ||||||
|
|
||||||||
|
Loss from discontinued operations, net of income
tax benefit of $0.1 million
|
| (102,038 | ) | |||||
|
|
||||||||
|
Net income
|
1,729,140 | 1,299,562 | ||||||
|
|
||||||||
|
Preferred stock dividend requirements
|
(74,867 | ) | (105,533 | ) | ||||
|
|
||||||||
|
Net income available to common shareholders
|
$ | 1,654,273 | $ | 1,194,029 | ||||
|
|
||||||||
|
|
||||||||
|
Basic earnings (loss) per share
available to common shareholders:
|
||||||||
|
Continuing operations
|
$ | 2.95 | $ | 2.38 | ||||
|
Discontinued operations
|
| (0.19 | ) | |||||
|
|
||||||||
|
|
||||||||
|
Net basic earnings per share
available to common shareholders
|
$ | 2.95 | $ | 2.19 | ||||
|
|
||||||||
|
Diluted earnings (loss) per share
available to common shareholders:
|
||||||||
|
Continuing operations
|
$ | 2.32 | $ | 1.64 | ||||
|
Discontinued operations
|
| (0.12 | ) | |||||
|
|
||||||||
|
Net diluted earnings per share
available to common shareholders
|
$ | 2.32 | $ | 1.52 | ||||
|
|
||||||||
|
Weighted average shares outstanding:
|
||||||||
|
Basic
|
560,119 | 545,593 | ||||||
|
Diluted
|
745,223 | 856,052 | ||||||
4
| 2009 | 2008 | |||||||
|
|
||||||||
|
CASH FLOWS FROM OPERATING ACTIVITIES:
|
||||||||
|
Net income
|
$ | 1,729,140 | $ | 1,299,562 | ||||
|
Deduct: Loss from discontinued operations, net of tax
|
| (102,038 | ) | |||||
|
|
||||||||
|
Income from continuing operations
|
1,729,140 | 1,401,600 | ||||||
|
|
||||||||
|
Adjustments to reconcile net income from
continuing operations to net cash flows
from operating activities:
|
||||||||
|
Depreciation
|
338,099 | 310,334 | ||||||
|
Amortization
|
49,170 | | ||||||
|
Gain on sale of property and equipment
|
(16,935 | ) | (43,697 | ) | ||||
|
Stock based compensation
|
163,364 | 132,900 | ||||||
|
Net excess tax (benefit) deficiency
on equity-based awards
|
(107,048 | ) | 16,592 | |||||
|
Deferred income taxes
|
10,104 | 47,411 | ||||||
|
Provision for losses on doubtful accounts
|
16,426 | 77,006 | ||||||
|
Provision for losses on inventory obsolescence
|
76,703 | 92,790 | ||||||
|
|
||||||||
|
Changes in
assets and liabilities, net of effect of acquisition:
|
||||||||
|
Accounts receivable
|
4,695,589 | 3,791,365 | ||||||
|
Inventories
|
3,442,508 | 1,733,268 | ||||||
|
Prepaid and other current assets
|
(2,679,354 | ) | 833,568 | |||||
|
Other assets
|
519 | (351,942 | ) | |||||
|
Accounts payable
|
(1,329,456 | ) | 1,023,735 | |||||
|
Accrued expenses and accrued wages, salaries and bonuses
|
(2,127,887 | ) | (1,321,463 | ) | ||||
|
Income tax payable
|
(2,973,111 | ) | 572,219 | |||||
|
|
||||||||
|
Net cash flows from operating activities continuing operations
|
1,287,831 | 8,315,686 | ||||||
|
Net cash flows from operating activities discontinued operations
|
| 19,727 | ||||||
|
|
||||||||
|
Net cash flows from operating activities
|
1,287,831 | 8,335,413 | ||||||
|
|
||||||||
|
CASH FLOWS FROM INVESTING ACTIVITIES:
|
||||||||
|
Purchases of property and equipment
|
(596,612 | ) | (265,971 | ) | ||||
|
Proceeds from sales of property and equipment
|
34,306 | 71,900 | ||||||
|
Acquisition
|
(3,099,836 | ) | | |||||
|
|
||||||||
|
Net cash flows from investing activities
|
(3,662,142 | ) | (194,071 | ) | ||||
|
|
||||||||
|
CASH FLOWS FROM FINANCING ACTIVITIES:
|
||||||||
|
Net borrowings (payments) on bank credit agreement
|
2,769,851 | (7,866,594 | ) | |||||
|
Principal payments on long-term debt
|
(182,901 | ) | (197,731 | ) | ||||
|
Proceeds from exercise of stock options
|
66,411 | | ||||||
|
Net excess tax benefit (deficiency)
on equity-based awards
|
107,048 | (16,592 | ) | |||||
|
Dividends paid on preferred stock
|
(74,867 | ) | (105,533 | ) | ||||
|
Dividends on common stock
|
(103,181 | ) | (57,039 | ) | ||||
|
|
||||||||
|
Net cash flows from financing activities
|
2,582,361 | (8,243,489 | ) | |||||
|
|
||||||||
|
Net change in cash
|
208,050 | (102,147 | ) | |||||
|
|
||||||||
|
Cash, beginning of period
|
309,914 | 457,681 | ||||||
|
|
||||||||
|
Cash, end of period
|
$ | 517,964 | $ | 355,534 | ||||
|
|
||||||||
5
| 2009 | 2008 | |||||||
|
Supplemental disclosure of cash flow information:
|
||||||||
|
Cash paid during the period for interest
|
$ | 381,746 | $ | 544,238 | ||||
|
Cash paid during the period for income taxes
|
3,903,998 | 182,371 | ||||||
|
|
||||||||
|
Supplemental disclosure of non-cash information:
|
||||||||
|
Equipment acquisitions classified as accounts payable
|
21,512 | | ||||||
|
|
||||||||
|
Business acquisition (see Note 2):
|
||||||||
|
Inventory
|
1,981,498 | | ||||||
|
Property and equipment
|
122,978 | | ||||||
|
Customer relationships intangible asset
|
1,620,000 | | ||||||
|
Goodwill
|
300,360 | | ||||||
|
Note payable
|
500,000 | | ||||||
|
Contingent consideration
|
425,000 | | ||||||
6
| |
Our wholesale distribution segment (ADC) distributes consumer products
in the Central and Rocky Mountain regions of the United States.
|
| |
Our retail health food segment operates thirteen health food retail
stores located throughout the Midwest and Florida.
|
7
8
9
| Total Consideration (in millions): | Amount | |||
|
Cash
|
$ | 3.1 | ||
|
Note payable
|
0.5 | |||
|
Fair value of contingent consideration
|
0.4 | |||
|
|
||||
|
Fair value of consideration transferred
|
$ | 4.0 | ||
|
|
||||
| Weighted | ||||||||
| Average | ||||||||
| Amortization | ||||||||
| Amount | Period | |||||||
|
Inventory
|
$ | 2.0 | | |||||
|
Property and equipment
|
0.1 | 5 years | ||||||
|
Identifiable intangible assets:
|
||||||||
|
Customer relationships
|
1.6 | 8 years | ||||||
|
|
||||||||
|
Total identifiable net assets
|
3.7 | |||||||
|
Goodwill
|
0.3 | |||||||
|
|
||||||||
|
Total identifiable assets and goodwill
|
$ | 4.0 | ||||||
|
|
||||||||
10
| (In millions) | Period | Revenue | Net Income | |||||||
|
Actual Results from
|
10/30/09-12/31/09 | $ | 9.2 | $ | 0.1 | |||||
|
Supplemental pro forma results
|
10/01/09-12/31/09 | $ | 14.2 | $ | 0.1 | |||||
|
Supplemental pro forma results
|
10/01/08-12/31/08 | $ | 11.7 | $ | 0.0 | |||||
| Series A | Series B | |||||||
|
Date of issuance:
|
June 17, 2004 | October 8, 2004 | ||||||
|
Optionally redeemable beginning
|
June 18, 2006 | October 9, 2006 | ||||||
|
Par value (gross proceeds):
|
$ | 2,500,000 | $ | 2,000,000 | ||||
|
Number of shares:
|
100,000 | 80,000 | ||||||
|
Liquidation preference per share:
|
$ | 25.00 | $ | 25.00 | ||||
|
Conversion price per share:
|
$ | 30.31 | $ | 24.65 | ||||
|
Number of common shares in
which to be converted:
|
82,481 | 81,136 | ||||||
|
Dividend rate:
|
6.785 | % | 6.37 | % | ||||
11
| December | September | |||||||
| 2009 | 2009 | |||||||
|
Wholesale Distribution Segment
|
$ | 4,236,291 | $ | 3,935,931 | ||||
|
Retail Health Food Segment
|
1,912,877 | 1,912,877 | ||||||
|
|
||||||||
|
|
$ | 6,149,168 | $ | 5,848,808 | ||||
|
|
||||||||
| December | September | |||||||
| 2009 | 2009 | |||||||
|
Trademarks and tradenames
|
$ | 3,373,269 | $ | 3,373,269 | ||||
|
Customer relationships (less accumulated
amortization of $33,750)
|
1,586,250 | | ||||||
|
|
||||||||
|
|
$ | 4,959,519 | $ | 3,373,269 | ||||
|
|
||||||||
12
| Fiscal | Fiscal | Fiscal | Fiscal | |||||||||||||||||
| 2010/1/ | 2011 | 2012 | 2013 | Thereafter | ||||||||||||||||
|
Customer relationships
|
151,875 | 202,500 | 202,500 | 202,500 | 826,875 | |||||||||||||||
|
|
||||||||||||||||||||
| /1/ |
Represents amortization for the remaining nine months of Fiscal 2010.
|
13
| For the three months ended December | ||||||||||||||||
| 2009 | 2008 | |||||||||||||||
| Basic | Diluted | Basic | Diluted | |||||||||||||
|
Weighted average common
shares outstanding
|
560,119 | 560,119 | 545,593 | 545,593 | ||||||||||||
|
|
||||||||||||||||
|
Weighted average of net
additional shares outstanding
assuming dilutive options
exercised and proceeds
used to purchase treasury
stock and conversion of
preferred stock /1/
|
| 185,104 | | 310,459 | ||||||||||||
|
|
||||||||||||||||
|
Weighted average number of
shares outstanding
|
560,119 | 745,223 | 545,593 | 856,052 | ||||||||||||
|
|
||||||||||||||||
|
|
||||||||||||||||
|
Income from continuing operations
|
$ | 1,729,140 | $ | 1,729,140 | $ | 1,401,600 | $ | 1,401,600 | ||||||||
|
Deduct: preferred stock
dividend requirements /2/
|
(74,867 | ) | | (105,533 | ) | | ||||||||||
|
|
||||||||||||||||
|
|
1,654,273 | 1,729,140 | 1,296,067 | 1,401,600 | ||||||||||||
|
|
||||||||||||||||
|
Loss from discontinued
operations
|
$ | | $ | | $ | (102,038 | ) | $ | (102,038 | ) | ||||||
|
|
||||||||||||||||
|
Net income available
to common shareholders
|
$ | 1,654,273 | $ | 1,729,140 | $ | 1,194,029 | $ | 1,299,562 | ||||||||
|
|
||||||||||||||||
|
Income per share from
continuing operations
|
$ | 2.95 | $ | 2.32 | $ | 2.38 | $ | 1.64 | ||||||||
|
|
||||||||||||||||
|
Loss per share from
discontinued operations
|
$ | | $ | | $ | (0.19 | ) | $ | (0.12 | ) | ||||||
|
|
||||||||||||||||
|
Net earnings per share
available to common shareholders
|
$ | 2.95 | $ | 2.32 | $ | 2.19 | $ | 1.52 | ||||||||
|
|
||||||||||||||||
| /1/ |
Diluted earnings per share calculation includes all stock options,
Convertible Preferred Stock, and restricted stock, in each case, that
are deemed to be dilutive.
|
|
| /2/ |
Diluted earnings per share calculation excludes dividend payments for
Convertible Preferred Stock deemed to be dilutive, as those amounts
are assumed to have been converted to common stock of the Company.
|
| |
A June 2011 maturity date.
|
| |
A $55.0 million revolving credit limit, plus the outstanding balance on Term Note A. Term
Note A had an outstanding balance of $0.1 million at December 2009.
|
| |
The Facility bears interest at either the banks prime rate or at LIBOR plus 250 basis
points, at the election of the Company.
|
14
| |
The Facility provides for an additional $5.0 million of credit available for certain
inventory purchases. These advances bear interest at the banks prime rate plus one-quarter
of one-percent (1/4%) per annum and are payable within 45 days of each advance.
|
| |
Lending limits subject to accounts receivable and inventory limitations, and an unused
commitment fee equal to one-quarter of one percent (1/4%) per annum on the difference between
the maximum loan limit and average monthly borrowings.
|
| |
Collateral including all of the Companys equipment, intangibles, inventories, and accounts
receivable.
|
| |
Provides that the Company may not pay dividends on its common stock in excess of $0.72 per
share on an annual basis.
|
| |
The Facility includes a prepayment penalty equal to one-half of one percent (
1
/
2
%) of the
original maximum loan limit ($60.4 million) if the Company prepays the entire Facility or
terminates the credit agreement on or before June 30, 2010.
|
15
| Number of | ||||||||||||
| Options | Number | |||||||||||
| Date | Exercise Price | Outstanding | Exercisable | |||||||||
|
Fiscal 2000
|
$ | 34.50 | 1,456 | 1,456 | ||||||||
|
Fiscal 2003
|
$ | 28.80 | 629 | 629 | ||||||||
|
Fiscal 2007
|
$ | 18.00 | 25,000 | 25,000 | ||||||||
|
|
||||||||||||
|
|
27,085 | 27,085 | ||||||||||
|
|
||||||||||||
| Number of | ||||||||||||
| Options | Number | |||||||||||
| Date | Exercise Price | Outstanding | Exercisable | |||||||||
|
Fiscal 2002
|
$ | 26.94 | 834 | 834 | ||||||||
|
|
||||||||||||
| Remaining | Exercisable | |||||||||||||||||||||||
| Exercise | Number | Weighted-Average | Weighted-Average | Number | Weighted-Average | |||||||||||||||||||
| Price | Outstanding | Contractual Life | Exercise Price | Exercisable | Exercise Price | |||||||||||||||||||
|
2000 Options
|
$ | 34.50 | 1,456 | 0.45 years | $ | 34.50 | 1,456 | $ | 34.50 | |||||||||||||||
|
2002 Options
|
$ | 26.94 | 834 | 2.62 years | $ | 26.94 | 834 | $ | 26.94 | |||||||||||||||
|
2003 Options
|
$ | 28.80 | 629 | 2.79 years | $ | 28.80 | 629 | $ | 28.80 | |||||||||||||||
|
2007 Options
|
$ | 18.00 | 25,000 | 6.95 years | $ | 18.00 | 25,000 | $ | 18.00 | |||||||||||||||
|
|
||||||||||||||||||||||||
|
|
27,919 | $ | 19.37 | 27,919 | $ | 19.37 | ||||||||||||||||||
|
|
||||||||||||||||||||||||
16
| Weighted | ||||||||
| Number | Average | |||||||
| of | Exercise | |||||||
| Shares | Price | |||||||
|
Outstanding at September 2009
|
30,126 | $ | 20.16 | |||||
|
Granted
|
| | ||||||
|
Exercised
|
(2,207 | ) | $ | 30.09 | ||||
|
Forfeited/Expired
|
| | ||||||
|
|
||||||||
|
Outstanding at December 2009
|
27,919 | $ | 19.37 | |||||
|
|
||||||||
| Restricted Stock /1/ | Restricted Stock /2/ | |||||||
|
Date of award:
|
December 6, 2007 | January 29, 2008 | ||||||
|
Number of shares:
|
24,000 | 7,500 | ||||||
|
Service period:
|
34 months | 36 months | ||||||
|
Estimated fair value of
award at grant date/3/:
|
$ | 963,000 | $ | 229,000 | ||||
|
Intrinsic value of awards
outstanding at December 2009:
|
$ | 528,000 | $ | 330,000 | ||||
| /1/ |
16,000 shares were vested at December 2009. The remaining 8,000 shares will vest on October 16, 2010.
|
|
| /2/ |
2,500 shares were vested at December 2009. The remaining 5,000 shares will vest in equal amounts (2,500 per year) on
January 29, 2010 and January 29, 2011.
|
|
| /3/ |
Amount is net of estimated forfeitures.
|
17
| Number | Weighted Average | |||||||
| of | Grant Date | |||||||
| Shares | Fair Value | |||||||
|
Nonvested restricted stock at September 2009
|
21,000 | $ | 40.16 | |||||
|
Granted
|
| | ||||||
|
Vested
|
(8,000 | ) | $ | 42.50 | ||||
|
Expired
|
| | ||||||
|
|
||||||||
|
Nonvested restricted stock at December 2009
|
13,000 | $ | 38.72 | |||||
|
|
||||||||
18
| Wholesale | ||||||||||||||||
| Distribution | Retail | Other /1/ | Consolidated | |||||||||||||
|
THREE MONTHS ENDED DECEMBER 2009:
|
||||||||||||||||
|
External revenue:
|
||||||||||||||||
|
Cigarettes
|
$ | 177,584,045 | $ | | $ | | $ | 177,584,045 | ||||||||
|
Confectionery
|
15,307,821 | | | 15,307,821 | ||||||||||||
|
Health food
|
| 8,926,489 | | 8,926,489 | ||||||||||||
|
Tobacco, food service & other
|
42,122,683 | | | 42,122,683 | ||||||||||||
|
|
||||||||||||||||
|
Total external revenue
|
235,014,549 | 8,926,489 | | 243,941,038 | ||||||||||||
|
Depreciation
|
266,580 | 70,372 | 1,147 | 338,099 | ||||||||||||
|
Amortization
|
49,170 | | | 49,170 | ||||||||||||
|
Operating income (loss)
|
3,998,612 | 917,307 | (1,853,914 | ) | 3,062,005 | |||||||||||
|
Interest expense
|
122,197 | 124,624 | 158,424 | 405,245 | ||||||||||||
|
Income (loss) from continuing
operations before taxes
|
3,879,649 | 802,830 | (2,012,339 | ) | 2,670,140 | |||||||||||
|
Total assets
|
74,327,598 | 11,729,960 | 978,068 | 87,035,626 | ||||||||||||
|
Capital expenditures
|
437,314 | 159,297 | | 596,611 | ||||||||||||
| Wholesale | ||||||||||||||||
| Distribution | Retail | Other /1/ | Consolidated | |||||||||||||
|
THREE MONTHS ENDED DECEMBER 2008:
|
||||||||||||||||
|
External revenue:
|
||||||||||||||||
|
Cigarettes
|
$ | 152,262,945 | $ | | $ | | $ | 152,262,945 | ||||||||
|
Confectionery
|
15,461,696 | | | 15,461,696 | ||||||||||||
|
Health food
|
| 8,980,794 | | 8,980,794 | ||||||||||||
|
Tobacco, food service & other
|
40,671,928 | | | 40,671,928 | ||||||||||||
|
|
||||||||||||||||
|
Total external revenue
|
208,396,569 | 8,980,794 | | 217,377,363 | ||||||||||||
|
Depreciation
|
248,164 | 61,023 | 1,147 | 310,334 | ||||||||||||
|
Amortization
|
| | | | ||||||||||||
|
Operating income (loss)
|
3,288,077 | 587,839 | (1,139,184 | ) | 2,736,732 | |||||||||||
|
Interest expense
|
132,679 | 169,545 | 186,975 | 489,199 | ||||||||||||
|
Income (loss) from continuing
operations before taxes
|
3,159,150 | 428,609 | (1,326,159 | ) | 2,261,600 | |||||||||||
|
Total assets
|
71,535,006 | 11,341,987 | 4,025,032 | 86,902,025 | ||||||||||||
|
Capital expenditures
|
128,490 | 137,481 | | 265,971 | ||||||||||||
| /1/ |
Includes intercompany eliminations, charges incurred by the holding company, and assets of
discontinued operations.
|
19
| Item 2. |
Managements Discussion and Analysis of Financial Condition and
Results of Operations
|
| |
increases in state and federal excise taxes on cigarette and tobacco products, including
recent increases in federal excise taxes imposed in connection with the State Childrens
Health Insurance Program (SCHIP) law,
|
| |
regulation of cigarette and tobacco products by the U.S. Food and Drug Administration
(FDA), in addition to existing state and federal regulations by other agencies,
|
| |
potential bans imposed by the FDA on the manufacture, distribution, and sale of certain
cigarette and tobacco products,
|
| |
increases in manufacturer prices,
|
| |
increases in inventory carrying costs and customer credit risk,
|
| |
changes in promotional and incentive programs offered by manufacturers,
|
| |
decreased availability of capital resources,
|
| |
demand for the Companys products, particularly cigarette and tobacco products,
|
| |
new business ventures or acquisitions,
|
| |
domestic regulatory and legislative risks,
|
| |
competition,
|
| |
poor weather conditions,
|
| |
increases in fuel prices,
|
| |
consolidation trends within the convenience store industry,
|
| |
other risks over which the Company has little or no control, and
|
| |
any other factors not identified herein.
|
20
| |
acquired the distribution assets of Discount Distributors, a wholesale distributor to
convenience stores with annual sales of approximately $59.8 million.
|
| |
recorded net income available to common shareholders of $1.7 million, a $0.5 million increase
over Q1 2009.
|
| |
paid a $0.18 dividend per common share, an 80% increase over Q1 2009.
|
21
22
23
| For the three months ended December | ||||||||||||||||
| Incr | ||||||||||||||||
| 2009 | 2008 | (Decr) | % Change | |||||||||||||
|
CONSOLIDATED:
|
||||||||||||||||
|
Sales /1/
|
$ | 243,941,038 | $ | 217,377,363 | $ | 26,563,675 | 12.2 | |||||||||
|
Cost of sales
|
226,713,025 | 201,532,714 | 25,180,311 | 12.5 | ||||||||||||
|
Gross profit
|
17,228,013 | 15,844,649 | 1,383,364 | 8.7 | ||||||||||||
|
Gross profit percentage
|
7.1 | % | 7.3 | % | ||||||||||||
|
Operating expense
|
14,166,008 | 13,107,917 | 1,058,091 | 8.1 | ||||||||||||
|
Operating income
|
3,062,005 | 2,736,732 | 325,273 | 11.9 | ||||||||||||
|
Interest expense
|
405,245 | 489,199 | (83,954 | ) | (17.2 | ) | ||||||||||
|
Income tax expense
|
941,000 | 860,000 | 81,000 | 9.4 | ||||||||||||
|
Income from continuing operations
|
1,729,140 | 1,401,600 | 327,540 | 23.4 | ||||||||||||
|
|
||||||||||||||||
|
BUSINESS SEGMENTS:
|
||||||||||||||||
|
Wholesale
|
||||||||||||||||
|
Sales
|
$ | 235,014,549 | $ | 208,396,569 | $ | 26,617,980 | 12.8 | |||||||||
|
Gross profit
|
13,386,777 | 12,197,029 | 1,189,748 | 9.8 | ||||||||||||
|
Gross profit percentage
|
5.7 | % | 5.9 | % | ||||||||||||
|
Retail
|
||||||||||||||||
|
Sales
|
$ | 8,926,489 | $ | 8,980,794 | $ | (54,305 | ) | (0.6 | ) | |||||||
|
Gross profit
|
3,841,236 | 3,647,620 | 193,616 | 5.3 | ||||||||||||
|
Gross profit percentage
|
43.0 | % | 40.6 | % | ||||||||||||
| /1/ |
Sales are reported net of costs associated with incentives provided to retailers. These incentives totaled $3.8 million in both Q1 2010 and Q1 2009.
|
| (i) |
changes to selling prices, which are largely controlled by our product suppliers, and
excise taxes imposed on cigarettes and tobacco products by various states; and
|
| (ii) |
changes in the volume of products sold to our customers, either due to a change in
purchasing patterns resulting from consumer preferences or the fluctuation in the comparable
number of business days in our reporting period.
|
| |
$9.2 million increase in sales related the acquisition of Discount Distributors during the
period.
|
| |
$32.0 million increase in cigarette sales due to price increases implemented by manufacturers
as compared to Q1 2009.
|
| |
$15.9 million decrease in sales, primarily related to a reduction in cigarette cartons sold
as compared to Q1 2009.
|
24
25
| Q1 2010 | Q1 2009 | |||||||
|
Operating loss
|
| (44,129 | ) | |||||
|
Interest expense
|
| (116,009 | ) | |||||
|
Income tax benefit
|
| (58,000 | ) | |||||
|
Loss from discontinued operations
|
| (102,038 | ) | |||||
| |
Operating Activities.
The Company requires cash to pay operating expenses, purchase
inventory, and make capital investments. In general, the Company finances its cash flow
requirements with cash generated from operating activities and credit facility borrowings.
During Q1 2010, the Company generated cash of approximately $1.3 million from operating
activities. The cash generated resulted from higher overall earnings and reductions in
accounts receivable and inventory. These items were partially offset by an increase in prepaid
and other assets and reductions in accounts payable, accrued expenses, and income taxes
payable.
|
|
|
Our variability in cash flows from operating activities is dependent on the timing of inventory
purchases and seasonal fluctuations. For example, periodically we have inventory buy-in
opportunities which offer more favorable pricing terms. As a result, we may have to hold
inventory for a period longer than the payment terms. This generates a cash outflow from
operating activities which we expect to reverse in later periods. Additionally, during the warm
weather months, which is our peak time of operations, we generally carry higher amounts of
inventory to ensure high fill rates and customer satisfaction.
|
26
| |
Investing Activities.
The Company used approximately $3.7 million of cash during Q1 2010
for investing activities, primarily related to the acquisition of the distribution assets of
Discount Distributors.
|
| |
Financing Activities.
The Company generated cash of $2.6 million for financing activities
during Q1 2010. Of this amount, $2.8 million related to net advances on the Companys credit
facility which was used to fund the Companys acquisition of Discount Distributors, and $0.2
million related to the exercise of stock options. Offsetting these items was $0.2 million of
payments on long-term debt, and $0.2 million related to dividends on the Companys common and
preferred stock.
|
| |
Cash on Hand/Working Capital. At December 2009, the Company had cash on hand of $0.5 million
and working capital (current assets less current liabilities) of $39.4 million. This compares
to cash on hand of $0.3 million and working capital of $35.7 million at September 2009.
|
| |
A June 2011 maturity date.
|
| |
A $55.0 million revolving credit limit, plus the outstanding balance on Term Note A. Term
Note A had an outstanding balance of $0.1 million at December 2009.
|
| |
The Facility bears interest at either the banks prime rate or at LIBOR plus 250 basis
points, at the election of the Company.
|
| |
The Facility provides for an additional $5.0 million of credit available for certain
inventory purchases. These advances bear interest at the banks prime rate plus one-quarter
of one-percent (1/4%) per annum and are payable within 45 days of each advance.
|
| |
Lending limits subject to accounts receivable and inventory limitations, and an unused
commitment fee equal to one-quarter of one percent (1/4%) per annum on the difference between
the maximum loan limit and average monthly borrowings.
|
| |
Collateral including all of the Companys equipment, intangibles, inventories, and accounts
receivable.
|
| |
Provides that the Company may not pay dividends on its common stock in excess of $0.72 per
share on an annual basis.
|
| |
The Facility includes a prepayment penalty equal to one-half of one percent (1/2%) of the
original maximum loan limit ($60.4 million) if the Company prepays the entire Facility or
terminates the credit agreement on or before June 30, 2010.
|
27
28
| Item 3. |
Quantitative and Qualitative Disclosures About Market Risk.
|
| Item 4. |
Controls and Procedures
|
29
| Item 1. |
Legal Proceedings
|
| Item 1A. |
Risk Factors
|
30
| Item 2. |
Unregistered Sales of Equity Securities and Use of Proceeds
|
| Item 3. |
Defaults Upon Senior Securities
|
| Item 4. |
Submission of Matters to a Vote of Security Holders
|
| Item 5. |
Other Information
|
| Item 6. |
Exhibits
|
| 31.1 |
Certification by Christopher H. Atayan, Chief Executive Officer and Chairman, furnished
pursuant to section 302 of the Sarbanes-Oxley Act
|
|||
|
|
||||
| 31.2 |
Certification by Andrew C. Plummer, Vice President, Chief Financial Officer, and Principal
Financial Officer furnished pursuant to section 302 of the Sarbanes-Oxley Act
|
|||
|
|
||||
| 32.1 |
Certification by Christopher H. Atayan, Chief Executive Officer and Chairman, furnished
pursuant to section 906 of the Sarbanes-Oxley Act
|
|||
|
|
||||
| 32.2 |
Certification by Andrew C. Plummer, Vice President, Chief Financial Officer, and Principal
Financial Officer furnished pursuant to section 906 of the Sarbanes-Oxley Act
|
31
|
AMCON DISTRIBUTING COMPANY
(registrant) |
||||
| Date: January 18, 2010 | /s/ Christopher H. Atayan | |||
| Christopher H. Atayan, | ||||
| Chief Executive Officer and Chairman | ||||
| Date: January 18, 2010 | /s/ Andrew C. Plummer | |||
| Andrew C. Plummer, | ||||
|
Vice President, Chief Financial Officer, and
Principal Financial Officer |
||||
32
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|